Updated Jul 16, 2026
Shapiro Aron has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Aron Shapiro is identified in the provided SEC filing context as a Director of Kiora Pharmaceuticals Inc. as of 2026-06-12. The available data do not provide additional verified biographical details such as education, prior roles, or tenure. No confirmation of broader public prominence is available from the provided information.
| Role | Director |
|---|---|
| Notability | 20/100 |
Aron Shapiro is identified in the provided SEC filing context as a Director of Kiora Pharmaceuticals Inc. as of 2026-06-12. The available data do not provide additional verified biographical details such as education, prior roles, or tenure. No confirmation of broader public prominence is available from the provided information.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Shapiro Aron profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.